 |
|
Effect of Hysterectomy vs Medical Treatment on Health-Related Quality of Life and Sexual Functioning
The Medicine or Surgery (Ms) Randomized Trial
Miriam Kuppermann, PhD, MPH;
R. Edward Varner, MD;
Robert L. Summitt, Jr, MD;
Lee A. Learman, MD, PhD;
Christine Ireland, MPH;
Eric Vittinghoff, PhD;
Anita L. Stewart, PhD;
Feng Lin, MS;
Holly E. Richter, PhD, MD;
Jonathan Showstack, PhD, MPH;
Stephen B. Hulley, MD, MPH;
A. Eugene Washington, MD, MSc; for the Ms Research Group
JAMA. 2004;291:1447-1455.
Context Although a quarter of US women undergo elective hysterectomy before menopause, controlled trials that evaluate the benefits and harms are lacking.
Objective To compare the effect of hysterectomy vs expanded medical treatment on health-related quality of life.
Design, Setting, and Participants A multicenter, randomized controlled trial (August 1997–December 2000) of 63 premenopausal women, aged 30 to 50 years, with abnormal uterine bleeding for a median of 4 years who were dissatisfied with medical treatments, including medroxyprogesterone acetate. The participants, who were patients at gynecology clinics and affiliated practices of 4 US academic medical centers, were followed up for 2 years.
Interventions Participants were randomly assigned to undergo hysterectomy or expanded medical treatment with estrogen and/or progesterone and/or a prostaglandin synthetase inhibitor. The hysterectomy route and medical regimen were determined by the participating gynecologist.
Main Outcome Measures The primary outcome was mental health measured by the Mental Component Summary (MCS) of the 36-Item Short-Form Health Survey (SF-36). Secondary outcomes included physical health measured by the Physical Component Summary (PCS), symptom resolution and satisfaction, body image, and sexual functioning, as well as other aspects of mental health and general health perceptions.
Results At 6 months, women in the hysterectomy group had greater improvement in MCS scores than women in the medicine group (8 vs 2, P = .04). They also had greater improvement in symptom resolution (75 vs 29, P<.001), symptom satisfaction (44 vs 7, P<.001), interference with sex (41 vs 22, P = .003), sexual desire (21 vs 3, P = .01), health distress (33 vs 13, P = .009), sleep problems (13 vs 1, P = .03), overall health (12 vs 2, P = .006), and satisfaction with health (31 vs 14, P = .01). By the end of the study, 17 (53%) of the women in the medicine group had requested and received hysterectomy, and these women reported improvements in quality-of-life outcomes during the 2 years that were similar to those reported by women randomized to the hysterectomy group. Women who continued medical treatment also reported some improvements (P<.001 for within-group change in many outcomes), with the result that most differences between randomized groups at the end of the study were no longer statistically significant in the intention-to-treat analysis.
Conclusions Among women with abnormal uterine bleeding and dissatisfaction with medroxyprogesterone, hysterectomy was superior to expanded medical treatment for improving health-related quality-of-life after 6 months. With longer follow-up, half the women randomized to medicine elected to undergo hysterectomy, with similar and lasting quality-of-life improvements; those who continued medical treatment also reported some improvements.
Author Affiliations: Departments of Obstetrics, Gynecology, and Reproductive Sciences (Drs Kuppermann, Learman, and Washington and Ms Lin), Epidemiology and Biostatistics (Drs Vittinghoff and Hulley and Mss Ireland and Lin), and Institute for Health Policy Studies (Dr Showstack), School of Nursing, Institute for Health and Aging (Dr Stewart), University of California, San Francisco; Department of Obstetrics and Gynecology, University of Alabama, Birmingham (Drs Varner and Richter); and Department of Obstetrics and Gynecology, University of Tennessee, Memphis (Dr Summitt).
RELATED ARTICLES
Clinical Outcomes and Costs With the Levonorgestrel-Releasing Intrauterine System or Hysterectomy for Treatment of Menorrhagia: Randomized Trial 5-Year Follow-up
Ritva Hurskainen, Juha Teperi, Pekka Rissanen, Anna-Mari Aalto, Seija Grenman, Aarre Kivelä, Erkki Kujansuu, Sirkku Vuorma, Merja Yliskoski, and Jorma Paavonen
JAMA. 2004;291(12):1456-1463.
ABSTRACT
| FULL TEXT
Evaluating Gynecological Surgical Procedures: Trials and Tribulations
Roy M. Pitkin and James R. Scott
JAMA. 2004;291(12):1503-1504.
EXTRACT
| FULL TEXT
Hysterectomy
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2004;291(12):1526.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Symptomatic Uterine Fibroids: Treatment with Uterine Artery Embolization or Hysterectomy--Results from the Randomized Clinical Embolisation versus Hysterectomy (EMMY) Trial
Hehenkamp et al.
Radiology 2008;246:823-832.
ABSTRACT
| FULL TEXT
Surgical versus Nonsurgical Therapy for Lumbar Spinal Stenosis
Weinstein et al.
NEJM 2008;358:794-810.
ABSTRACT
| FULL TEXT
Effect of Noncancerous Pelvic Problems on Health-Related Quality of Life and Sexual Functioning
Kuppermann et al.
Obstet Gynecol 2007;110:633-642.
ABSTRACT
| FULL TEXT
Oophorectomy in Premenopausal Women: Health-Related Quality of Life and Sexual Functioning
Teplin et al.
Obstet Gynecol 2007;109:347-354.
ABSTRACT
| FULL TEXT
Surgical vs Nonoperative Treatment for Lumbar Disk Herniation: The Spine Patient Outcomes Research Trial (SPORT): A Randomized Trial
Weinstein et al.
JAMA 2006;296:2441-2450.
ABSTRACT
| FULL TEXT
Abnormal Uterine Bleeding: A Management Algorithm
Ely et al.
J Am Board Fam Med 2006;19:590-602.
ABSTRACT
| FULL TEXT
Sexual Functioning After Total Compared With Supracervical Hysterectomy: A Randomized Trial
Kuppermann et al.
Obstet Gynecol 2005;105:1309-1318.
ABSTRACT
| FULL TEXT
23 Apr 2004 to 23 Jul 2004
Evid. Based Nurs. 2004;7:e4-e4.
FULL TEXT
Other articles noted
Evid. Based Med. 2004;9:e5-e5.
FULL TEXT
Alternatives to Hysterectomy -- What Do Women Want?
JWatch Women's Health 2004;2004:4-4.
FULL TEXT
Hysterectomy Versus Expanded Medical Treatment for Abnormal Uterine Bleeding: Clinical Outcomes in the Medicine or Surgery Trial
Learman et al.
Obstet Gynecol 2004;103:824-833.
ABSTRACT
| FULL TEXT
Is Hysterectomy the Best Treatment for Abnormal Uterine Bleeding?
JWatch General 2004;2004:2-2.
FULL TEXT
Evaluating Gynecological Surgical Procedures: Trials and Tribulations
Pitkin and Scott
JAMA 2004;291:1503-1504.
FULL TEXT
|
